An overview of contraception in women with obesity

被引：1
作者：
Hammad, Wafaa Ali Belail [1 ]
Gupta, Neerja [2 ]
Konje, Justin C. [3 ,4 ,5 ]
机构：
[1] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Basildon, England
[2] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon, England
[3] Feto Maternal Ctr, Doha, Qatar
[4] Weill Cornell Med, Obstet & Gynecol, Ar Rayyan, Qatar
[5] Univ Leicester, Dept Hlth Sci, Obstet & Gynaecol, Leicester, England
来源：
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY | 2023年 / 91卷
关键词：
Obesity; Contraception; Pharmacokinetics; Safety; Combined hormonal contraception; Implants and lactational amenorrhea; DEPOT MEDROXYPROGESTERONE ACETATE; NONFATAL VENOUS THROMBOEMBOLISM; AMENORRHEA METHOD LAM; EMERGENCY CONTRACEPTION; ORAL-CONTRACEPTIVES; BODY-WEIGHT; INTRAUTERINE-DEVICE; ULIPRISTAL ACETATE; TRANSDERMAL PATCH; ETHINYL ESTRADIOL;
D O I：
10.1016/j.bpobgyn.2023.102408
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The use of safe and effective contraception is essential for pre-venting unplanned pregnancy in women of all body sizes. When counseling women with obesity about contraception, it is impor-tant to consider the pharmacokinetic alterations of obesity on various modern contraceptive methods. However, evidence is reassuring that most contraceptive methods are safe and effective in women with obesity. Individual countries and the World Health Organization have published Medical Eligibility Criteria to guide contraceptive selection in women with medical issues including obesity. When choosing contraception, specific risks of the method relative to any underlying medical disorders must also be balanced against the risks of unintended pregnancy in this group.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页数：13
相关论文
共 79 条
[61]   The efficacy and safety of an oral contraceptive containing chlormadinone acetate: results of a pooled analysis of noninterventional trials in adult and adolescent women [J].
Schramm, Georg A. K. ;
Schrah, Guido .
CONTRACEPTION, 2011, 84 (04) :390-401
[62]   Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously [J].
Segall-Gutierrez, Penina ;
Taylor, DeShawn ;
Liu, Xinwen ;
Stanzcyk, Frank ;
Azen, Stanley ;
Mishell, Daniel R., Jr. .
CONTRACEPTION, 2010, 81 (06) :487-495
[63]   Hormonal contraception and obesity [J].
Simmons, Katharine B. ;
Edelman, Alison B. .
FERTILITY AND STERILITY, 2016, 106 (06) :1282-1288
[64]   Contraception and sexual health in obese women [J].
Simmons, Katharine B. ;
Edelman, Alison B. .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2015, 29 (04) :466-478
[65]   Contraception with two levonorgestrel rod implants -: A 5-year study in the United States and Dominican Republic [J].
Sivin, I ;
Alvarez, F ;
Mishell, DR ;
Darney, P ;
Wan, LV ;
Brache, V ;
Lacarra, M ;
Klaisle, C ;
Stern, J .
CONTRACEPTION, 1998, 58 (05) :275-282
[66]   Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval [J].
Smit, J ;
Botha, J ;
McFadyen, L ;
Beksinska, M .
CONTRACEPTION, 2004, 69 (01) :3-7
[67]   Contraceptive considerations in obese women [J].
不详 .
CONTRACEPTION, 2009, 80 (06) :583-590
[68]  
The Centers for Disease Control and Prevention, BMI categories
[69]   Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) - A systematic enquiry and overview [J].
Varma, Rajesh ;
Sinha, Deepali ;
Gupta, Janesh K. .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 125 (01) :9-28
[70]   Oral contraceptive failures and body weight: Findings in a large cohort study [J].
Vessey, M ;
Painter, R .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2001, 27 (02) :90-91
12345678